{"entity":{"type":"insider","cik":"0001678149","url":"/insider/0001678149","json_url":"/insider/0001678149.json","name":"Olson Eric R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2017-07-27","last":"2023-07-18","span_basis":"filed_date"},"name_variants":[{"name":"Olson Eric R","source":"filing","n_filings":9,"first_seen":"2017-07-27","last_seen":"2023-07-18"}],"transactions":[{"id":8295403,"accession":"0001209191-23-042669","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042669","line_url":"/filing/0001209191-23-042669#line-1","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001678149","owner_name":"Olson Eric R","owner_display_name":"Olson Eric R","owner_url":"/insider/0001678149","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":689.0,"shares_display":"689","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":2411.5,"total_display":"2,411.50","total_whole":"2,412","shares_owned_after":6661.0,"shares_owned_after_display":"6,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-18","scope":"insider"},{"id":6446490,"accession":"0001209191-22-002216","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-002216","line_url":"/filing/0001209191-22-002216#line-1","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001678149","owner_name":"Olson Eric R","owner_display_name":"Olson Eric R","owner_url":"/insider/0001678149","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2208.0,"shares_display":"2,208","price_per_share":3.4669,"price_display":"3.47","price_state":"stated","total_value":7654.9152,"total_display":"7,654.92","total_whole":"7,655","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-06","scope":"insider"},{"id":5429093,"accession":"0001209191-21-044493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-044493","line_url":"/filing/0001209191-21-044493#line-1","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001678149","owner_name":"Olson Eric R","owner_display_name":"Olson Eric R","owner_url":"/insider/0001678149","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1164.0,"shares_display":"1,164","price_per_share":5.55,"price_display":"5.55","price_state":"stated","total_value":6460.2,"total_display":"6,460.20","total_whole":"6,460","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-01","scope":"insider"},{"id":4555834,"accession":"0001209191-21-021428","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-021428","line_url":"/filing/0001209191-21-021428#line-2","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001678149","owner_name":"Olson Eric R","owner_display_name":"Olson Eric R","owner_url":"/insider/0001678149","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3628.0,"shares_display":"3,628","price_per_share":9.474,"price_display":"9.47","price_state":"stated","total_value":34371.672,"total_display":"34,371.67","total_whole":"34,372","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":2471941,"accession":"0001209191-20-047504","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-047504","line_url":"/filing/0001209191-20-047504#line-4","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001678149","owner_name":"Olson Eric R","owner_display_name":"Olson Eric R","owner_url":"/insider/0001678149","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10787.0,"shares_display":"10,787","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":140231.0,"total_display":"140,231.00","total_whole":"140,231","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-19","scope":"insider"},{"id":2471928,"accession":"0001209191-20-047504","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047504","line_url":"/filing/0001209191-20-047504#line-2","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001678149","owner_name":"Olson Eric R","owner_display_name":"Olson Eric R","owner_url":"/insider/0001678149","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4963.0,"shares_display":"4,963","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":64519.0,"total_display":"64,519.00","total_whole":"64,519","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":3258413,"accession":"0001209191-20-041574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-041574","line_url":"/filing/0001209191-20-041574#line-1","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001678149","owner_name":"Olson Eric R","owner_display_name":"Olson Eric R","owner_url":"/insider/0001678149","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1753.0,"shares_display":"1,753","price_per_share":11.7162,"price_display":"11.72","price_state":"stated","total_value":20538.4986,"total_display":"20,538.50","total_whole":"20,538","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2020-07-07","scope":"insider"},{"id":2985936,"accession":"0000899243-20-005283","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-005283","line_url":"/filing/0000899243-20-005283#line-1","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001678149","owner_name":"Olson Eric R","owner_display_name":"Olson Eric R","owner_url":"/insider/0001678149","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1446.0,"shares_display":"1,446","price_per_share":7.3818,"price_display":"7.38","price_state":"stated","total_value":10674.0828,"total_display":"10,674.08","total_whole":"10,674","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-20","scope":"insider"},{"id":5029486,"accession":"0001179110-17-011235","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-011235","line_url":"/filing/0001179110-17-011235#line-2","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001678149","owner_name":"Olson Eric R","owner_display_name":"Olson Eric R","owner_url":"/insider/0001678149","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":23.5876,"price_display":"23.59","price_state":"stated","total_value":58969.0,"total_display":"58,969.00","total_whole":"58,969","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-07","filed_date":"2017-08-08","scope":"insider"},{"id":4898940,"accession":"0001179110-17-010735","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-010735","line_url":"/filing/0001179110-17-010735#line-2","is_derivative":false,"issuer_cik":"0001556263","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001556263","owner_cik":"0001678149","owner_name":"Olson Eric R","owner_display_name":"Olson Eric R","owner_url":"/insider/0001678149","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":21.85,"price_display":"21.85","price_state":"stated","total_value":273125.0,"total_display":"273,125.00","total_whole":"273,125","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-25","filed_date":"2017-07-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001556263","name":"Syros Pharmaceuticals, Inc.","url":"/issuer/0001556263","role":"Officer (Chief Scientific Officer)","n_filings":9,"first_seen":"2017-07-27","last_seen":"2023-07-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001678149","retrieved_at":"2026-08-22T18:43:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}